The Role of KRIs in Process-Driven RBQM Success

Using key risk indicators (KRIs) can improve clinical trial data quality in 80% of the sites on average.

Guide

A Comprehensive Guide to Adaptive Site Monitoring

Blog

RBQM for the Mid-Market Explained

Mid-market sponsors are expected to meet the same ICH E6(R3) standards as large pharma, often with...

Blog

5 Myths Mid-Market Teams Believe About RBQM and What ICH E6(R3) Actually Requires

Risk-Based Quality Management (RBQM) is no longer a future-state concept. Under ICH E6(R3), it is a...

Blog

Modern RBQM Has Evolved. Is Your Organization Ready?

Most sponsors and CROs are now fluent in the language of Risk-Based Quality Management (RBQM). Terms...